PWB
Invesco Large Cap Growth ETF · PSE
- Category Large Cap
- Expense Ratio 0.56%
- Listing Date Mar 03, 2005
- Volume 23,093.0
- Market Cap (AUM) $844.93M
Performance
+4.2%
1W
-0.19%
1M
+2.21%
3M
+25.29%
6M
+14.24%
YTD
+36.68%
1Y
Top Holdings
-
Name
Symbol%Assets
- NVIDIA CorporationNVDA4.11%
- Alphabet Inc. Class AGOOGL3.93%
- Amazon.com, Inc.AMZN3.68%
- Oracle CorporationORCL3.53%
- Broadcom Inc.AVGO3.36%
- Costco Wholesale CorporationCOST3.36%
- Eli Lilly and CompanyLLY3.33%
- Microsoft CorporationMSFT3.29%
- Netflix, Inc.NFLX3.27%
- Mastercard Incorporated Class AMA3.25%
Technical Analysis of PWB 2024-05-10
Overview:
In analyzing the technical indicators for PWB stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potentia...
Recent News & Updates
- 2021-11-04 03:27
- 2020-05-28 01:00
5 Reasons to Bet on Growth ETFs(Yahoo Finance)
- 2020-01-09 22:05
Why You Should Buy Growth ETFs Now(Yahoo Finance)
- 2018-01-18 21:33
What Praxairs Short Interest Suggests before 4Q17 Earnings(Marketrealist)
- 2017-12-08 03:05
4 Smart Beta ETFs for Long Term Investors(Yahoo Finance)
- 2017-10-30 02:17
Buy 5 Top-Ranked ETFs on High P/E for Further Gains(Yahoo Finance)
- 2017-10-13 00:17
- 2017-08-09 21:07
Whats Priced into Marriotts Valuation Multiple Now?(Marketrealist)
- 2017-08-09 03:05
Could Marriotts Partnership with Alibaba Be a Game Changer?(Marketrealist)
- 2017-08-06 21:09
Why Investors Should Pay Attention to Marriotts Debt Levels(Marketrealist)
- 2017-08-03 01:05
What Should We Make of Pricelines Increasing Leverage?(Marketrealist)
- 2017-07-30 21:10
Eli Lilly in 2Q17: Oncology Products Lose Revenues(Marketrealist)
- 2017-06-20 22:37
Bristol-Myers Squibb Reported Revenue Growth in 1Q17(Marketrealist)
- 2017-06-01 22:36
Performance of Eli Lillys Endocrine Products in 1Q17(Marketrealist)
- 2017-05-01 22:36
Eli Lilly & Co.s Developments in 1Q17(Marketrealist)
- 2017-04-20 00:55
4 Ways to Get Involved With Impact Investing(Investopedia)
- 2017-03-30 22:36
Exploring Eli Lillys Oncology Franchise in 2016(Marketrealist)
- 2017-03-16 19:38
A Look at Opdivos Performance in 2016(Marketrealist)
- 2017-02-26 20:06
Eli Lilly & Co.s Oncology Franchise(Marketrealist)
- 2017-01-30 02:05
Bristol-Myers Squibbs Strong Oncology Segment(Marketrealist)
- 2017-01-25 21:36
What to Expect from Eli Lillys Oncology Franchise in 4Q16(Marketrealist)
- 2017-01-17 20:55
ETFs in Focus on Robust Q4 UnitedHealth Earnings(Yahoo Finance)
- 2016-11-27 19:04
- 2016-11-25 00:04
- 2016-11-23 19:04
What You Should Know about Eli Lillys Oncology Franchise(Marketrealist)
- 2016-10-19 22:04
Eli Lilly and Co.s 3Q16 Estimates: Oncology Franchise(Marketrealist)
- 2016-10-18 22:01
Buy UnitedHealth ETFs on Upbeat Q3 Earnings(Yahoo Finance)
- 2016-10-07 01:16
Is the Dividend ETF Bull Run Over?(Yahoo Finance)
- 2016-10-04 21:42
- 2016-09-18 20:04
- 2016-09-01 23:04
- 2016-08-31 23:04
How Are Eli Lillys Business Segments Performing?(Marketrealist)
- 2016-08-23 22:04
Why Did Hormel Foods Increase Its Fiscal 2016 Guidance?(Marketrealist)
- 2016-08-22 21:30
- 2016-08-19 03:51
- 2016-08-03 21:47
Top Tech ETFs Of 2016(Yahoo Finance)
- 2016-07-26 23:57
This Seasonal ETF Is Ripe For The Pickin' This Summer(Yahoo Finance)
- 2016-07-24 21:20
A Consumer Staples ETF To Feast On(Yahoo Finance)
- 2016-07-23 00:00
- 2016-07-12 05:05
Why Are So Many Analysts Rating B&G Foods a Hold?(Marketrealist)
Page 1 of 3
previousnext